References
- RabensteinDLHeparin and heparan sulfate: structure and functionNat Prod Rep200219331233112137280
- WeitzDSWeitzJIUpdate on heparin: what do we need to know?J Thromb Thrombolysis201029219920719882363
- BeniSLimtiacoJFLariveCKAnalysis and characterization of heparin impuritiesAnal Bioanal Chem2011399252753920814668
- LiuHZhangZLinhardtRJLessons learned from the contamination of heparinNat Prod Rep200926331319240943
- GunayNSLinhardtRJHeparinoids: structure, biological activities and therapeutic applicationsPlanta Med199965430130610364832
- AlbanSFranzGPartial synthetic glucan sulfates as potential new antithrombotics: a reviewBiomacromolecules20012235436111749192
- PaluckSJNguyenTHMaynardHDHeparin-mimicking polymers: synthesis and biological applicationsBiomacromolecules201617113417344027739666
- BalanVVerestiucLStrategies to improve chitosan hemocompatibility: A reviewEur Polym J201453171188
- MuzzarelliRATanfaniFEmanuelliMPaceDPChiurazziEPianiMSulfated N-(carboxymethyl)chitosans: novel blood anticoagulantsCarbohydr Res198412622252316713433
- HiranoSTanakaYHasegawaMTobettoKNishiokaAEffect of sulfated derivatives of chitosan on some blood coagulant factorsCarbohydr Res19851372052153986847
- FranzGAlbanSStructure-activity relationship of antithrombotic polysaccharide derivativesInt J Biol Macromol19951763113148789331
- HuangRduYYangJFanLInfluence of functional groups on the in vitro anticoagulant activity of chitosan sulfateCarbohydr Res2003338648348912668103
- Nud’gaLAPliskoEADanilovSNSynthesis and properties of sulfoethylchitosanZhurnal Prikl Khimi1974474872876
- MuzzarelliRAAModified chitosans carrying sulfonic acid groupsCarbohydr Polym1992194231236
- Nud’gaLAPetrovaVABen’kovichADPetropavlovskiiGAComparative study of reactivity of cellulose, chitosan, and chitin-glucan complex in sulfoethylationRuss J Appl Chem2001741145148
- PestovAVPetrovaYSBukharovaAVSynthesis in a gel and sorption properties of N-2-sulfoethyl chitosanRuss J Appl Chem2013862269272
- PetrovaYSBukharovaAVNeudachinaLKAdamovaLVKoryakovaOVPestovAVChemical properties of N-2-Sulfoethylchitosan with a medium degree of substitutionPolym Sci Ser B2014564487493
- PetrovaYSNeudachinaLKMekhaevAVPestovAVSimple synthesis and chelation capacity of N-(2-sulfoethyl)chitosan, a taurine derivativeCarbohydr Polym201411246246825129768
- PetrovaYSPestovAVUsoltsevaMKNeudachinaLKSelective adsorption of silver(I) ions over copper(II) ions on a sulfoethyl derivative of chitosanJ Hazard Mater201529969670126282087
- ZhangKBrendlerEGebauerKGrunerMFischerSSynthesis and characterization of low sulfoethylated celluloseCarbohydr Polym2011832616622
- FengTduYLiJHuYKennedyJFEnhancement of antioxidant activity of chitosan by irradiationCarbohydr Polym2008731126132
- KumarBAVaradarajMCTharanathanRNLow molecular weight chitosan – preparation with the aid of pepsin, characterization, and its bactericidal activityBiomacromolecules20078256657217256986
- ChaeSYJangMKNahJWInfluence of molecular weight on oral absorption of water soluble chitosansJ Control Release2005102238339415653159
- BreitwieserDSpirkSFaslHDesign of simultaneous antimicrobial and anticoagulant surfaces based on nanoparticles and polysaccharidesJ Mater Chem B201311520222030
- EhmannHMBreitwieserDWinterSGold nanoparticles in the engineering of antibacterial and anticoagulant surfacesCarbohydr Polym2015117344225498606
- HolappaJNevalainenTSavolainenJSynthesis and characterization of chitosan N-betainates having various degrees of substitutionMacromolecules200437827842789
- TravanAPelilloCDonatiINon-cytotoxic silver nanoparticle-polysaccharide nanocomposites with antimicrobial activityBiomacromolecules20091061429143519405545
- MessmoreHLCoyneEWehrmacherWHDemirAMFareedJStudies comparing low molecular weight heparin with heparin for the treatment of thromboembolism: a literature reviewCurr Pharm Des20041091001101015078129
- SeoPLockeCFCurrent and potential uses of low molecular weight heparin: a review and an economic analysisAm J Manag Care20006449850610977456
- BrooksMBEvaluation of a chromogenic assay to measure the factor Xa inhibitory activity of unfractionated heparin in canine plasmaVet Clin Pathol200433420821415570557
- RosénSCasoniMCHeparin therapy and monitoring: a role for the chromogenic antifactor Xa assayAm Clin Lab20012073538
- EganGEnsomMHMeasuring anti-factor xa activity to monitor low-molecular-weight heparin in obesity: a critical reviewCan J Hosp Pharm2015681334725762818
- ZiaAO’BrienSHGlobal coagulation assays: a clinical perspectiveJ Thromb Thrombolysis2015391899425244973
- SuchmanALGrinerPFDiagnostic uses of the activated partial thromboplastin time and prothrombin timeAnn Intern Med198610468103706933
- BatesSMWeitzJIAssaysCCoagulation assaysCirculation20051124e53e6016043649